Owner Serologicals Investment Company

Inventors Williams, Stephen Geraint; Crombie, Robert Lachlan

Agent FB Rice

Pub. Number AU-B-2002242872

PCT Pub. Number WO2002/081677

Priority 60/281,605 05.04.01 US; 0109335.0 17.04.01 GB; 0108605.7 05.04.01 GB; 60/298,675 15.06.01 US

Filing date 5 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 14 December 2006

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/7052 (2006.01)

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione